Complete News, Your Way.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Eurovision
Artificial Intelligence
Social Media
Sanctions
Soccer
Donald Trump
Education
Real Estate
Infrastructure
Inflation
UK Economy
European Union
Published • loading... • Updated

Tyk2 Inhibition Prevents Islet Inflammation and Delays Type 1 Diabetes Development in Mice

Summary by dermatologytimes.com
New research reveals a promising strategy to slow type 1 diabetes progression by targeting inflammation with an existing psoriasis drug.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

All
Left
Center
Right
dermatologytimes.comdermatologytimes.com

Tyk2 Inhibition Prevents Islet Inflammation and Delays Type 1 Diabetes Development in Mice

New research reveals a promising strategy to slow type 1 diabetes progression by targeting inflammation with an existing psoriasis drug.

Read Full Article
Managed Healthcare ExecutiveManaged Healthcare Executive

Mouse Study Shows Psoriasis Drug Sotyktu Could Treat Type 1 Diabetes

Researchers have found that Sotyktu, which inhibits the protein TYK2, protects insulin-producing beta cells and, at the same time, is able to reduce inflammation.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Managed Healthcare Executive broke the news in on Tuesday, May 13, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Research

Research

News
For You
SearchBlindspotLocal